Regenesis · 1 day ago
Sales Manager
Maximize your interview chances
Insider Connection @Regenesis
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Performs initial and follow-up sales calls on prospective and current clients.
Conducts product in-services to current clients as needed.
Must be knowledgeable in all aspects of the use, operation and maintenance of system.
Must be knowledgeable in all aspects of competitor products.
Develops sales plan according to the objectives of the company.
Documents sales activity for supervisor.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
This position is field based, and the incumbent will travel approximately 80% of the time within the territory.
Responsible for initial and follow-up sales calls on prospective and current clients for all patients to explain the use of our Pain Management device indicated for post-procedural pain and edema.
Selling to VAs and VA Community Based Outpatient Clinics (CBOCs).
Performs initial and follow-up sales calls on prospective and current clients.
Conducts product in-services to current clients as needed.
Must be knowledgeable in all aspects of the use, operation and maintenance of system.
Must be knowledgeable in all aspects of competitor products.
Develops sales plan according to the objectives of the company.
Documents sales activity for supervisor.
Preferred
One year of sales experience in the medical field
Familiarity with medical terminology as it pertains to pain management
Military veteran experience preferred, based on current business with national VA facilities
Company
Regenesis
Regenesis is a device company dedicated to improving human welfare through the research, design, manufacture, and sale of energy-based medical products and services that alleviate pain to improve quality of life.
Funding
Current Stage
Growth StageTotal Funding
$11.73MKey Investors
Fulcrum Equity Partners
2011-06-06Series C· $5.3M
2008-05-22Series B· $2.79M
2006-08-21Series B· $0.53M
Recent News
2024-04-15
2024-04-15
Company data provided by crunchbase